1. Market Research
  2. > Biotechnology
  3. > Genomics Proteomics and Enabling Technology Market Trends
Fluidigm Patent Portfolio Analysis

Fluidigm Patent Portfolio Analysis

  • May 2017
  • 83 pages
  • ID: 5168526
  • Format: PDF
  • By KnowMade

Summary

Table of Contents

FLUIDIGM HAS BEEN HIGHLY INNOVATIVE SINCE THE EARLY 2000s
The microfluidics device market is currently growing, with a wide scope of applications across many industries. According to our partner Yole Développement, the microfluidics device market is worth $2.5 billion in 2017. With an expected compound annual growth rate of 18%, this market is projected to reach $5.8 billion by 2022. This high growth rate is largely due to advances in biotechnology, including gene sequencing and genomics. FLUIDIGM is considered as a pioneer in these microfluidic technologies.

FLUIDIGM was founded in 1999 to market the integrated fluidic circuit based on a pneumatic rubber valve developed in the laboratory of Stephen Quake, then at Caltech. With this technology, FLUIDIGM became the first company to commercialize a digital polymerase chain reaction (PCR) product in 2006. In 2009, FLUIDIGM was described as “the world’s leading manufacturer of microfluidic devices“ by the Nanotechnology Business Journal. Today, among the applications in which FLUIDIGM products are put to use are single-cell genomics, gene expression, single nucleotide polymorphism (SNP) genotyping, targeted resequencing, sample quantitation, copy number variation and mass cytometry. FLUIDIGM started developing its patent portfolio in the early 2000s and the number of new patents filed each year by FLUIDIGM has remained stable since then. Moreover, FLUIDIGM acquired numerous patents from HELICOS BIOSCIENCES, DVS SCIENCES and ARCXIS BIOTECHNOLOGIES. In recent years, FLUIDIGM’s total revenue has decreased. This decline in revenue was partly due to lower sales for genomic products. Therefore, in order to find new growth engines, technologies patented by FLUIDIGM have evolved considerably since its inception. This technological diversification exposes FLUIDIGM to new competitors, especially some big patent assignees that may assert their patents and other proprietary rights against FLUIDIGM.

CITATION NETWORK AND COMPETITIVE IP ENVIRONMENT
FLUIDIGM’s patent portfolio has been cited by more than 700 patent assignees in more than 2300 patent families. For its part, FLUIDIGM cites 2600 patent families in its portfolio, representing around 900 assignees. Combining the citation network with the analysis of the content of citing/cited patents, FLUIDIGM’s IP competitors have been ranked in order to establish a general view of the competitive IP environment. Thus IP competitors developing microfluidic technologies have been identified for various applications such as protein crystallization, next-generation sequencing (NGS) and digital PCR, single cell genomics or mass cytometry.

IDENTIFY BLOCKING PATENTS
Analyzing citations and citing applicants, FLUIDIGM’s patents with a high potential for IP blocking of other patent applicants in the field of microfluidics have been identified. Most of those patents are related to single cell analysis or digital PCR. Several of these patents were acquired by FLUIDIGM from other companies, or co-filed with academics. The IP blocking power of product categories and applications claimed by FLUIDIGM was also analyzed.

IDENTIFY KEY PATENTS
Key patents have been identified based on several indicators, including family size, legal status, citation analysis and impact on microfluidic technology. Newly granted patents, recently expired patents and patents expiring in the next few years have also been analyzed. Several patents were granted recently in the USA, Europe and China, in particular in the field of mass cytometry.

This report also includes an Excel database containing all of the analyzed patents. This database allows for multi-criteria searches and includes patent publication number, hyperlinks to the original documents, priority date, title, abstract, patent assignees and legal status for each member of the patent family.

ASSIGNEES CITED IN THE REPORT
3M, ABBOTT, AFFYMETRIX, AGENA BIOSCIENCE, AGILENT TECHNOLOGIES, ARCXIS BIOTECHNOLOGIES, BD, BECKMAN COULTER, BIO-RAD, CALIPER, CALTECH, COMPLETE GENOMICS, DOW, DVS SCIENCES, FLUIDIGM, GE HEALTHCARE, GPB SCIENTIFIC, HANDYLAB, HELICOS BIOSCIENCES, HITACHI, HYALOS THERAPEUTICS, IBM, ILLUMINA, INTEGENX, LECO, LGC, LIFE TECHNOLOGIES, LUMINEX, NATERA, OPKO, PACIFIC BIOSCIENCES, PERKINELMER, PHILIPS, QUANTERIX, RAINDANCE, ROCHE, SEQLL, SEQUENOM, SHIMADZU, SIEMENS, SONY, THERMO FISHER SCIENTIFIC, UNIVERSITY OF BRITISH COLUMBIA, UNIVERSITY OF CALIFORNIA, UNIVERSTY OF CALIFORNIA

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Asia Pacific Oligonucleotide Synthesis Market to 2027 - Regional Analysis and Forecasts by Product, Application, End User, and Country

Asia Pacific Oligonucleotide Synthesis Market to 2027 - Regional Analysis and Forecasts by Product, Application, End User, and Country

  • $ 3000
  • October 2019

The Asia Pacific oligonucleotide synthesis market is expected to reach US$ 872.98 Mn in 2027 from US$ 334.26 Mn in 2018. The market is estimated to grow with a CAGR of 14.7% from 2019-2027.The growth of ...

Global Blockchain in Genomics Market: Focus on Business Models, Services, Applications, End Users, 11 Countries Data, and Competitive Landscape – Analysis and Forecast, 2019-2029

Global Blockchain in Genomics Market: Focus on Business Models, Services, Applications, End Users, 11 Countries Data, and Competitive Landscape – Analysis and Forecast, 2019-2029

  • $ 5000
  • September 2019

Global Blockchain in Genomics Market to Grow at a CAGR of 66.42% from 2019-2029Key Questions Answered in the Report:• What are the major market drivers, challenges, and opportunities in the global blockchain ...

Global RNA Interference (RNAi) Industry

Global RNA Interference (RNAi) Industry

  • $ 5450
  • October 2019

RNA Interference (RNAi) market worldwide is projected to grow by US$39.9 Billion, driven by a compounded growth of 18.5%. Drug Discovery & Development, one of the segments analyzed and sized in this study, ...

Global Epigenetics Industry $ 5450 October 2019


ref:plp2017

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on